Lars Klareskog Selected Research

Rheumatoid Arthritis

11/2022	Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis.
11/2022	Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis.
1/2022	Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology.
1/2022	Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA Registry.
1/2022	Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control study.
12/2021	Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis.
7/2021	Rheumatoid arthritis autoantibodies and their association with age and sex.
1/2021	The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study.
1/2021	A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
1/2021	Haplotype-Specific Expression Analysis of MHC Class II Genes in Healthy Individuals and Rheumatoid Arthritis Patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Klareskog Research Topics

Disease

180	Rheumatoid Arthritis 11/2022 - 08/2003
25	Arthritis (Polyarthritis) 01/2021 - 01/2002
21	Inflammation (Inflammations) 01/2022 - 01/2004
13	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2008
9	Pain (Aches) 01/2022 - 08/2014
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 09/2003
5	Periodontitis 01/2022 - 07/2014
5	Rheumatic Diseases (Rheumatism) 01/2020 - 02/2004
4	Joint Diseases (Joint Disease) 12/2021 - 11/2010
4	Arthralgia (Joint Pain) 01/2020 - 07/2013
4	Necrosis 01/2016 - 01/2006
4	Lymphoma (Lymphomas) 04/2008 - 06/2003
3	Synovitis 01/2022 - 01/2006
3	Multiple Sclerosis 12/2009 - 05/2005
3	Experimental Arthritis 06/2009 - 01/2005
2	Hypersensitivity (Allergy) 01/2022 - 01/2022
2	COVID-19 12/2021 - 01/2021
2	Human Influenza (Influenza) 01/2021 - 04/2007
2	Psoriatic Arthritis 01/2021 - 11/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 03/2009
2	Neoplasms (Cancer) 02/2014 - 11/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014 - 11/2010
2	Asthma (Bronchial Asthma) 02/2010 - 02/2004
2	Myasthenia Gravis 11/2009 - 09/2008
2	Infections 10/2007 - 01/2004
2	Tetanus 04/2007 - 01/2007
2	Celiac Disease (Celiac Sprue) 02/2005 - 06/2002
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022
1	Edema (Dropsy) 01/2022

Drug/Important Bio-Agent (IBA)

58	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2004
43	AntibodiesIBA 01/2022 - 06/2002
41	Anti-Citrullinated Protein AntibodiesIBA 11/2022 - 08/2007
31	AutoantibodiesIBA 01/2022 - 01/2004
29	Peptides (Polypeptides)IBA 01/2022 - 01/2008
24	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 01/2004
23	EpitopesIBA 01/2022 - 06/2004
23	acetyl 4-aminosalicylic acidIBA 10/2020 - 01/2009
16	AntigensIBA 12/2021 - 01/2004
12	Immunoglobulin G (IgG)IBA 01/2021 - 06/2002
12	AutoantigensIBA 12/2018 - 01/2002
12	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 02/2004
10	Rheumatoid FactorIBA 01/2021 - 06/2004
10	Biomarkers (Surrogate Marker)IBA 12/2018 - 05/2008
9	Collagen Type II (Type II Collagen)IBA 09/2020 - 01/2005
9	CitrullineIBA 12/2018 - 01/2005
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 09/2003
7	Etanercept (Enbrel)FDA Link 11/2009 - 02/2004
6	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 06/2010
6	Tumor Necrosis Factor InhibitorsIBA 01/2011 - 05/2004
6	Infliximab (Remicade)FDA Link 06/2010 - 01/2005
5	Antirheumatic Agents (DMARD)IBA 12/2021 - 04/2006
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 04/2014
5	Immunoglobulin A (IgA)IBA 01/2021 - 06/2002
5	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 10/2004
4	ChemokinesIBA 12/2019 - 04/2016
4	ORALIT (ORS)IBA 01/2019 - 03/2006
4	EnzymesIBA 01/2018 - 01/2005
4	cyclic citrullinated peptideIBA 09/2017 - 01/2004
4	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 01/2004
4	Fibrinogen (Factor I)FDA Link 06/2015 - 05/2010
4	Pharmaceutical PreparationsIBA 01/2015 - 02/2004
3	serum P-component (CIt)IBA 12/2021 - 01/2005
3	Biological ProductsIBA 12/2021 - 01/2013
3	HLA-DQA1 antigen (HLA DQA1)IBA 01/2021 - 01/2012
3	HLA-B Antigens (HLA-B)IBA 01/2021 - 01/2012
3	Amino Acids FDA Link 01/2021 - 01/2012
3	SmokeIBA 01/2019 - 01/2011
3	C-Reactive ProteinIBA 01/2018 - 01/2016
3	ametantrone (HAQ)IBA 09/2017 - 08/2014
3	TNF Receptor-Associated Factor 1IBA 02/2011 - 09/2007
3	CytokinesIBA 07/2010 - 12/2005
2	Monoclonal AntibodiesIBA 01/2022 - 01/2019
2	HLA-DPB1 antigen (HLA DPB1)IBA 01/2021 - 01/2012
2	HLA-A Antigens (HLA-A)IBA 01/2021 - 01/2012
2	Interleukin-8 (Interleukin 8)IBA 12/2019 - 02/2017
2	LipidsIBA 01/2019 - 09/2003
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2006
2	Protein-Arginine DeiminasesIBA 01/2018 - 11/2012
2	Prednisolone (Predate)FDA LinkGeneric 05/2015 - 01/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013 - 01/2007
2	VimentinIBA 05/2013 - 01/2008
2	Phosphopyruvate Hydratase (Enolase)IBA 05/2013 - 12/2009
2	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 02/2012 - 01/2005
2	Prostaglandin-E SynthasesIBA 08/2011 - 11/2005
2	golimumab FDA Link 06/2010 - 01/2010
2	Interferon-gamma (Interferon, gamma)IBA 12/2009 - 05/2005
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2007 - 09/2003
2	triamcinolone hexacetonide (Aristospan)FDA Link 05/2006 - 12/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2006 - 02/2004
2	OilsIBA 01/2005 - 01/2002
2	MineralsIBA 01/2005 - 01/2002
2	GoldIBA 08/2003 - 01/2002
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2022
1	MetalsIBA 01/2022

Therapy/Procedure

18	Therapeutics 01/2021 - 05/2004
3	Aftercare (After-Treatment) 01/2017 - 10/2006
2	Duration of Therapy 10/2007 - 06/2003
1	Immunotherapy 11/2022